Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium carbonate and methimazole in newly diagnosed Graves' disease
ChiCTR-TRC-13003463Phase 4Recruiting
- Sponsor
- Endocrine and Diabetes Center, Jiangsu Province Hospital on Integration of Chinese and Western Medicine
- Start
- Sep 2013
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lithium carbonate and methimazole in Graves' disease and hyperthyroidism (3 arms), sponsored by Endocrine and Diabetes Center, Jiangsu Province Hospital on Integration of Chinese and Western Medicine. Primary endpoints: Total thyroxine, Total triiodothyronine and 7 more. Started Sep 2013; status: recruiting.
02
Drugs
lithium carbonatemethimazole
03
Conditions
Graves' diseasehyperthyroidism
Beyond the preview
Go deeper on ChiCTR-TRC-13003463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003463.